Skip to main content
FinSpry Logo
FinSpry
CHRS logo
CHRS
(NASDAQ)
Coherus Oncology, Inc.
$1.73-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Coherus Oncology (CHRS) Stock Price & Financial Analysis

Coherus Oncology Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$1.69 - $1.76
52-Week High$2.62
52-Week Low$0.71
Open$1.70
Volume537.23K
Average Volume (3M)537.23K
Market Cap208.24M
Shares Outstanding120.37M
Price to Sales (P/S)4.97
Price to Book (P/B)3.43
EV/EBITDA-0.70
Revenue (TTM)42.17M
Net Income (TTM)-170.29M
EPS (TTM)$-1.41
Profit Margin-403.80%
Operating Margin-425.72%
Return on Equity (ROE)-279.10%
Debt to Equity0.05
50-Day MA$1.83
200-Day MA$1.41
52-Week Change115.83%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About Coherus Oncology

What is the current stock price for CHRS?

As of the latest trading session, CHRS stock trades at $1.73. The 52-week range is $0.71–$2.62, with a day range of $1.69–$1.75.

What is the P/E ratio for CHRS?

The P/E ratio (Price-to-Earnings) for CHRS is shown in the Key Statistics section. This valuation metric helps compare Coherus Oncology, Inc. to industry peers.

Does CHRS pay dividends?

Coherus Oncology does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for CHRS?

Based on 1 analyst, the consensus for CHRS is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of CHRS?

Coherus Oncology's market capitalization is $208.2M, classifying it as a micro-cap company. Coherus Oncology operates in the Healthcare sector within the Biotechnology industry.